We're sorry, this listing is off the market. Try these listings instead:

Pharmaceutical Company – GI Cancer #461969 posted Jan 31, 2017

  • United States
  • Available On Request

The company’s lead compounds are indicated for the GI cancer space where Actionable Genetics are not driving stratification (>80% of human cancer falls into this category). The company’s leadership team has the ideal academic and industrial background to tackle the question of how to select for novel...

Pharma Co. for Sale – Radiation Blocking #462765 posted Feb 13, 2017

  • United States
  • Available On Request

The company has an FDA approved drug for radiation blocking. Current customers include the US and multiple Middle East governments. Sales have been strong given the constant threat of a nuclear plant accident or a terrorist act. The company is highly profitable with 2015 EBITDA of USD 4,500,000 with...

Orphan Drug Pharma Co. - Systemic Scleroderma #469030 posted May 24, 2017

  • Tennessee, United States
  • Available On Request

The client is a US based pharmaceutical company with a mid-stage orphan drug treatment for systemic scleroderma. The drug has been granted orphan drug status by the FDA and the EMEA (European Medicines Agency). The company is looking for capital or a partner to complete a pivotal clinical trial which...